ALK amplification or mutation was identified in ∼14% of neuroblastomas (NBs), the most common extracranial childhood tumour (Chen et al, 2008; George et al, 2008; Janoueix-Lerosey et al, 2008; Mosse et al, 2008). This evidence concerns the gene ALK and neoplasm.